Harrow, Inc. (HROW)
Nasdaq: HROW · Pharmaceutical Preparations · Nashville, TN · filing with the SEC since 2006
Grade5.8
◀ Past 5.8● Present 6.3▶ Future 5.4
Filings
323 filings since 2017 beside 190 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Apr 24, 2026.
Filings a yearinsider forms included
4948785541485642
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Sep 4, 2026.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Sep 19, 2025.A late-filing notice, Form NT 10-K, filed Mar 17, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Oct 5, 2026
8-K items 1.01, 2.01, 7.01, 9.01
Major agreement signed; Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report
Oct 1, 2026
Aug 10, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Aug 6, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Aug 3, 2026
May 11, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Mar 27, 2026
8-K items 1.01, 2.03, 8.01, 9.01
Major agreement signed; New debt or obligation taken on; Other event · Current report
Mar 24, 2026
Mar 2, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Feb 2, 2026
8-K items 2.02, 5.02, 9.01
Results released; Officer or director change · Current report
Jan 30, 2026
Nov 18, 2025
8-K items 2.01, 3.02, 8.01, 9.01
Purchase or sale of a business completed; Shares sold without registration; Other event · Current report
Nov 17, 2025
Nov 10, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Aug 11, 2025
Oct 6, 2025
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Oct 1, 2025
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
Sep 24, 2025
Sep 29, 2025
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
Sep 26, 2025
Sep 26, 2025
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Sep 24, 2025
Sep 12, 2025
8-K items 1.01, 2.03, 8.01, 9.01
Major agreement signed; New debt or obligation taken on; Other event · Current report
Sep 8, 2025
40 of 323 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.